(E)-5-dodecenal | 68820-34-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (E)-5-dodecenal
• 英文别名: trans-Dodec-5-enal；(E)-dodec-5-enal
• CAS: 68820-34-8
• 化学式: C₁₂H₂₂O
• 分子量: 182.306
• InChiKey: MXYKXSMSECVABY-BQYQJAHWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  13
• 可旋转键数：
  9
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• [EN] PEPTIDE COMPOUNDS<br/>[FR] COMPOSÉS PEPTIDIQUES
  申请人：ULTUPHARMA AB

  公开号：WO2020046190A1

  公开（公告）日：2020-03-05

  The present invention relates to novel compounds, which presents a peptide structure and an unexpected antibacterial effect even against certain multiresistant bacteria. The compounds may becyclic peptides, sometimes depsipeptides, ornon-ring-closed peptides, asdefined by Formula (I). Further, the invention relates to the medical use of the herein claimed compounds, a method for the production of the compounds as well as a method of treatment including the compounds. In addition, the invention relates to a pharmaceutical preparation comprising one or more of the herein described and claimed compounds combined with suitable carrier(s) and/or adjuvant(s). Finally, the invention is the use of one or more of the claimed compounds in a method for decolonization of a surface of Gram-positive and/or Gram-negative bacteria.

  本发明涉及一种新型化合物，其具有肽结构并且具有出乎意料的抗菌效果，甚至对某些多重耐药细菌也有效。这些化合物可能是环肽，有时是脱氨肽，或者是非环闭合肽，如公式（I）所定义。此外，本发明涉及所述化合物的医药用途，一种生产该化合物的方法以及包括该化合物的治疗方法。此外，本发明还涉及一种制药制剂，其中包括一种或多种所述化合物，结合适当的载体和/或辅料。最后，本发明是利用一种或多种所述化合物在去除革兰氏阳性和/或阴性细菌表面的方法中的应用。
• Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use
  申请人：Sankyo Company Limited

  公开号：EP0536936A1

  公开（公告）日：1993-04-14

  Compounds of formula (I): [in which: R¹, R² and R³ are the same or different and each represents a hydrogen atom, an optionally substituted alkanoyl group or an alkenylcarbonyl group, provided that at least one of R¹, R² and R³ represents an unsubstituted alkanoyl group having from 5 to 24 carbon atoms, said substituted alkanoyl group or said alkenylcarbonyl group; and one of R⁴ and R⁵ represents a hydrogen atom and the other represents a cyano group]; have valuable anti-tumour activity.

  式子（I）的化合物：[其中：R¹、R²和R³相同或不同，每个代表氢原子、可选取代的脂肪酰基团或烯基羰基团，前提是至少有一个R¹、R²和R³代表有5到24个碳原子的未取代脂肪酰基团，或者是所述取代的脂肪酰基团或所述烯基羰基团；R⁴和R⁵中的一个代表氢原子，另一个代表氰基]，具有有价值的抗肿瘤活性。
• Carbostyril derivatives
  申请人：OTSUKA PHARMACEUTICAL CO., LTD.

  公开号：EP0382185B1

  公开（公告）日：1994-06-15
• Lipid membrane structures
  申请人：DAIICHI SEIYAKU CO., LTD.

  公开号：EP0180980B1

  公开（公告）日：1991-03-13
• OXYTOCIN ANTAGONIST
  申请人：OTSUKA PHARMACEUTICAL CO., LTD.

  公开号：EP0602209A1

  公开（公告）日：1994-06-22

表征谱图